rxstat › Shortages › Ketorolac Tromethamine

Ketorolac Tromethamine shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Ketorolac Tromethamine products are in shortage in Canada (4 of 12 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Nov 6, 2026.
Products affected
4 / 12
In shortage since
Mar 10, 2017
Est. full return
Nov 6, 2026
Reports on file
57
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
ACULAR
0.5% · SOLUTION · ABBVIE CORPORATION
DIN 01968300 · since May 20, 2026, est. end Jul 14, 2026 · Demand increase for the drug.
Active shortage
KETOROLAC
0.5% · SOLUTION · AA PHARMA INC
DIN 02245821 · since Oct 7, 2025, est. end Nov 6, 2026 · Disruption of the manufacture of the drug.
Active shortage
KETOROLAC
0.5% · SOLUTION · AA PHARMA INC
DIN 02245821 · since Dec 30, 2025, est. end Nov 6, 2026 · Disruption of the manufacture of the drug.
Active shortage
KETOROLAC TROMETHAMINE INJECTION, USP
30MG · LIQUID · FRESENIUS KABI CANADA LTD
DIN 02244947 · since ?, est. end Jul 27, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-KETOROLAC INJECTABLE
30MG · SOLUTION · APOTEX INC
DIN 02243989 · since Mar 10, 2017, no end estimate · Other (Please describe in comments)
Anticipated
ACUVAIL
0.45% · SOLUTION · ABBVIE CORPORATION
DIN 02369362 · Disruption of the manufacture of the drug.
Discontinued
KETOROLAC TROMETHAMINE INJECTION USP
30MG · SOLUTION · PFIZER CANADA ULC
DIN 02390582
Discontinued
KETOROLAC TROMETHAMINE INJECTION USP
30MG · SOLUTION LIQUID · SANDOZ CANADA INCORPORATED
DIN 02239944
Resolved
KETOROLAC TROMETHAMINE INJECTION USP
30MG · SOLUTION LIQUID · SANDOZ CANADA INCORPORATED
DIN 02239944 · ended Aug 4, 2025 · Disruption of the manufacture of the drug.
Discontinued
ACULAR LS
0.4% · SOLUTION · ABBVIE CORPORATION
DIN 02248722
Resolved
APO-KETOROLAC
10MG · TABLET · APOTEX INC
DIN 02229080 · ended Mar 20, 2025 · Disruption of the manufacture of the drug.
Resolved
KETOROLAC
0.5% · SOLUTION · AA PHARMA INC
DIN 02245821 · ended Aug 13, 2024 · Disruption of the manufacture of the drug.

Showing 12 of 57 reports. All reports are on file with Health Canada.

What's happening

Ketorolac Tromethamine is currently affected by 4 active shortage reports filed with Health Canada by ABBVIE CORPORATION, AA PHARMA INC, FRESENIUS KABI CANADA LTD, APOTEX INC.

The reported causes are: demand increase for the drug; disruption of the manufacture of the drug; other (please describe in comments). Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Ketorolac Tromethamine is classified under “ANTIINFLAMMATORY AGENTS” (ATC S01BC).

Recent changes

Common questions

When will Ketorolac Tromethamine be back in stock in Canada?

The latest manufacturer estimate is Nov 6, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Ketorolac Tromethamine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antiinflammatory agents)

Partial shortageBromfenac1 of 2 reported products affected · est. return Mar 26, 2027Partial shortageDiclofenac5 of 34 reported products affected · est. return Sep 18, 2026Partial shortageDifluprednate1 of 1 reported products affected · est. return Jul 13, 2026No current shortageDexamethasoneDiscontinuedFluorometholone0 of 1 reported products affectedShortage anticipatedNepafenac0 of 2 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.